Bausch + Lomb Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BLCO | ALC | COO | HYB.F | AFX.DE | 7743.T | |
|---|---|---|---|---|---|---|
| Market cap | 7.36B | 37.37B | 12.25B | 44.46B | 3.15B | 23.76B |
| P/E (TTM) | — | 58.6 | 22.1 | 29.1 | 26.4 | 21.8 |
| Forward P/E | 17.3 | 19.6 | 13.7 | 32.5 | 24.6 | 17.0 |
| Price/book | 1.1 | 1.7 | 1.5 | 7.8 | 1.5 | 1.2 |
| Dividend yield | — | 0.46% | — | 1.31% | 1.57% | 1.91% |
| 1-year change | +32.65% | +4.09% | −11.69% | −4.30% | −18.22% | +39.18% |
| Today | +2.85% | +6.83% | +5.90% | −2.41% | +0.50% | 0.00% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 20 min.
Latest news
All BLCO news ›Top Players Alcon, AbbVie, Bausch + Lomb, and Johnson & Johnson in the Artificial Tears Market as It Reaches USD 6.5 Billion by 2036, Growing at 5.2% CAGR
Press release - Future Market Insights - Top Players Alcon, AbbVie, Bausch + Lomb, and Johnson & Johnson in the Artificial Tears Market as It Reaches USD 6.5 Billion by 2036, Growing at 5.2% CAGR - published on openPR.com Top Players…
Vitreous Tamponade Market Led by Alcon, Bausch + Lomb and Fluoron Drive Growth Through Heavy Silicone Oils and Short-Acting Gas Tamponades | SNS Insider
Vitreous Tamponade Market Growth Gains Pace as Vitreoretinal Surgery Volumes Rise According to a recent study by SNS Insider the global Vitreous Tamponade Market was valued at USD 89 85 million in 2025 and is projected to reach USD 161 ...…
HC Wainwright Downgrades Bausch + Lomb to Neutral From Buy, Price Target is $22
Bausch + Lomb has an average rating of overweight and mean price target of $21.92, according to analysts polled by FactSet. ... Bausch + Lomb Corporation Medical Equipment, Supplies & Distribution HC Wainwright Downgrades Bausch + Lomb to…
HC Wainwright Expects Stronger Earnings for Bausch + Lomb
Posted by Sarita Garza on Nov 3rd, 2026 View Our Latest Stock Report on BLCO Here are the key news stories impacting Bausch + Lomb this week: Its vision-care portfolio includes the Biotrue and INFUSE contact-lens brands, as well as…
Bausch + Lomb Soars 16% on Big Q3 Profit Beat and Raised Full-Year Guidance
max-kegfire from Getty Images via Canva Bausch + Lomb (BLCO) shares jumped 16% today after its third-quarter profit blew past expectations. Adjusted EPS came in at $0.34 against a $0.22 consensus, and revenue rose 7% to $1.375 billion. Its…
Bausch + Lomb Survey: Many With Dry Eye Self-Manage Symptoms
VAUGHAN, Ontario—Bausch + Lomb Corporation (NYSE/TSX: BLCO) announced publication of survey results that reveal consumer perspectives on dry eye. According to the results, self-reported dry eye symptoms were more common than reported…
Bausch + Lomb (NYSE:BLCO) Price Target Raised to $19.00
Posted by Tristan Rich on Nov 1st, 2026 Bausch + Lomb (NYSE:BLCO – Free Report) had its price target increased by Wells Fargo & Company from $18.00 to $19.00 in a research report released on Thursday morning,Benzinga reports. The firm…
More from 1 other outlet
Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Designed to reduce the operational burden that stands ...
RBC Raises Price Target on Bausch + Lomb to $23 From $21, Keeps Outperform Rating
Bausch + Lomb has an average rating of overweight and mean price target of $21.62, according to analysts polled by FactSet. ... Bausch + Lomb Corporation Medical Equipment, Supplies & Distribution RBC Raises Price Target on Bausch + Lomb…
Bausch + Lomb raises 2026 guidance to $5.450B-$5.550B revenue and $1.090B-$1.140B adjusted EBITDA as Vision '27 momentum continues
Bausch + Lomb Q3 2026 earnings: revenue rose 8%, margins expanded, and guidance increased again. Earnings Call Insights: Bausch + Lomb (BLCO) Q3 2026 - "This quarter represents another milestone for the company. It marks the fourth…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com6
- marketscreener.com4
- themarketsdaily.com4
- theglobeandmail.com3
- defenseworld.net2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 45 articles, not a forecast.